Advanced search
Publication Cover
Journal of Chemotherapy Volume 36, 2024 - Issue 4
Submit an article Journal homepage
44
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer

Syed Tabish Rehmana Medicine, Aga Khan University Medical College Pakistan, Karachi, PakistanORCID Iconhttps://orcid.org/0000-0003-1532-5978
ORCID Icon,
Syeda Mahnoor Azeemb Ziauddin Medical University, Ziauddin University, Karachi, Pakistan
,
Areeba Akbarc Liaquat College of Medicine and Dentistry, Karachi, Pakistan
,
Omer Shafiqd The Aga Khan University, Karachi, Pakistan
,
Syed Shehryar Azeemb Ziauddin Medical University, Ziauddin University, Karachi, Pakistan
&
Shabbir Hussain A. Alie Department of Oncology, Ziauddin Medical University, Ziauddin University, Karachi, PakistanCorrespondence[email protected]
Pages 329-333 | Received 27 Apr 2023, Accepted 30 Sep 2023, Published online: 14 Oct 2023

References

  • Thandra KC, Barsouk A, Saginala K, et al. Epidemiology of lung cancer. Contemp Oncol. 2021;25(1):45–52.
  • Teramoto A, Tsukamoto T, Kiriyama Y, et al. Automated classification of lung cancer types from cytological images using deep convolutional neural networks. Biomed Res Int. 2017;2017:4067832–4067836. doi:10.1155/2017/4067832.
  • Rizvi NA, Mazières J, Planchard D, et al. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 2015;16(3):257–265. doi:10.1016/S1470-2045(15)70054-9.
  • Chen YH, Liu FC, Hsu CH, et al. Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma. Medicine (Baltimore). 2017;96(27):e7350. doi:10.1097/MD.0000000000007350.
  • Xing P, Zhang F, Wang G, et al. Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO + IPI: a systematic review and meta-analysis. J Immunother Cancer. 2019;7(1):341. doi:10.1186/s40425-019-0779-6.
  • Wang DY, Salem JE, Cohen JV, et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 2018;4(12):1721–1728. doi:10.1001/jamaoncol.2018.3923.
  • Nakatani Y, Tanaka N, Enami T, et al. Lambert-Eaton myasthenic syndrome caused by nivolumab in a patient with squamous cell lung cancer. Case Rep Neurol. 2018;10(3):346–352. doi:10.1159/000494078.
  • Kesner VG, Oh SJ, Dimachkie MM, et al. Lambert-Eaton myasthenic syndrome. Neurol Clin. 2018;36(2):379–394. doi:10.1016/j.ncl.2018.01.008.
  • Zhang N, Hong D, Ouyang T, et al. 3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trials. BMC Neurol. 2021;21(1):371. doi:10.1186/s12883-021-02405-3.
  • Wang Y, Zhou S, Yang F, et al. Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials. JAMA Oncol. 2019;5(7):1008–1019. doi:10.1001/jamaoncol.2019.0393.
  • Zhou S, Khanal S, Zhang H. Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients. Ther Clin Risk Manag. 2019;15:211–221. doi:10.2147/TCRM.S193338.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.